Sunshine Biopharma (SBFMW) Gross Profit Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFMW) Gross Profit Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 5.06% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 2.59% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -7.66% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 42.12% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 49.07% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 14.77% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -163.22% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -2.85% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 7,497.38% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -20.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.12% |
| Dec 31, 2025 | -2.08% |
| Sep 30, 2025 | 7.24% |
| Jun 30, 2025 | 45.27% |
| Mar 31, 2025 | 15.97% |
| Dec 31, 2024 | 20.44% |
| Sep 30, 2024 | 44.01% |
| Jun 30, 2024 | 20.66% |
| Mar 31, 2024 | 28.78% |
| Dec 31, 2023 | 72.22% |
| Sep 30, 2023 | 2,869.42% |
| Jun 30, 2023 | 2,482.18% |
| Mar 31, 2023 | 2,811.02% |
| Dec 31, 2022 | 6,157.61% |
| Sep 30, 2022 | 117.12% |
| Jun 30, 2022 | 120.10% |
| Mar 31, 2022 | 191.58% |
| Dec 31, 2021 | 35.78% |
| Sep 30, 2021 | 185.57% |
| Jun 30, 2021 | 244.14% |